Partnership Opportunities Salomon's House offers an encoded library screening platform, creating a clear opportunity to generate revenue through partnerships with CROs and pharma companies seeking scalable discovery capabilities. Focus on co-development, sponsored research, or early-access programs to validate the platform and build case studies.

Growth Readiness Early-stage profile with modest revenue and a near-zero headcount signals readiness for partner-driven growth and potential investments. Position the company for seed or venture funding, government grants, and Tennessee biotech incentives to support platform scale, laboratory expansion, and talent onboarding.

Tech Enablement Tech-first R&D workflow indicated by the use of Microsoft 365, React, Immutable.js, and GoDaddy. This enables conversations around data management, collaboration tooling, and integration services to connect researchers with encoded library results, accelerating joint experiments and data sharing.

Regional Advantage Geographic positioning in Lebanon, Tennessee situates Salomon's House within the Tennessee life sciences ecosystem and near regional universities and healthcare networks. Leverage regional academic partnerships, talent pipelines, and local incentives to accelerate proof-of-concept studies and co-sponsorships.

Market Opportunity Strategic focus on life threatening diseases and infectious screening aligns with high-priority therapeutic areas and market demand for scalable discovery. Target early discovery teams at biotech startups and academic spin-outs, offering rapid screening capabilities to shorten development timelines.